A.R.T. Advisors’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-173,211
| Closed | -$624K | – | 1913 |
|
|
2019
Q3 | $624K | Buy |
173,211
+46,400
| +37% | +$167K | 0.03% | 764 |
|
|
2019
Q2 | $340K | Buy |
126,811
+76,500
| +152% | +$205K | 0.02% | 903 |
|
|
2019
Q1 | $149K | Buy |
+50,311
| New | +$149K | 0.01% | 1120 |
|
|
2018
Q4 | – | Sell |
-75,296
| Closed | -$277K | – | 1841 |
|
|
2018
Q3 | $277K | Buy |
+75,296
| New | +$277K | 0.01% | 1073 |
|
|
2018
Q2 | – | Sell |
-185,913
| Closed | -$689K | – | 1928 |
|
|
2018
Q1 | $689K | Buy |
185,913
+52,800
| +40% | +$196K | 0.03% | 809 |
|
|
2017
Q4 | $383K | Buy |
133,113
+50,400
| +61% | +$145K | 0.02% | 994 |
|
|
2017
Q3 | $371K | Sell |
82,713
-47,837
| -37% | -$215K | 0.02% | 938 |
|
|
2017
Q2 | $599K | Buy |
+130,550
| New | +$599K | 0.03% | 727 |
|
|
2017
Q1 | – | Sell |
-18,300
| Closed | -$75K | – | 1847 |
|
|
2016
Q4 | $75K | Sell |
18,300
-36,100
| -66% | -$148K | ﹤0.01% | 1186 |
|
|
2016
Q3 | $440K | Buy |
+54,400
| New | +$440K | 0.14% | 229 |
|
|
2016
Q2 | – | Sell |
-46,679
| Closed | -$360K | – | 1769 |
|
|
2016
Q1 | $360K | Buy |
+46,679
| New | +$360K | 0.02% | 981 |
|
|
2015
Q4 | – | Sell |
-394,723
| Closed | -$2.73M | – | 1840 |
|
|
2015
Q3 | $2.73M | Buy |
394,723
+155,844
| +65% | +$1.08M | 0.1% | 279 |
|
|
2015
Q2 | $2.12M | Buy |
238,879
+78,201
| +49% | +$693K | 0.07% | 422 |
|
|
2015
Q1 | $1.58M | Sell |
160,678
-65,293
| -29% | -$644K | 0.05% | 475 |
|
|
2014
Q4 | $2.77M | Sell |
225,971
-463,272
| -67% | -$5.67M | 0.1% | 278 |
|
|
2014
Q3 | $6.88M | Buy |
+689,243
| New | +$6.88M | 0.32% | 63 |
|
|
2013
Q4 | – | Sell |
-264,070
| Closed | -$797K | – | 1632 |
|
|
2013
Q3 | $797K | Sell |
264,070
-32,304
| -11% | -$97.5K | 0.04% | 598 |
|
|
2013
Q2 | $2.42M | Buy |
+296,374
| New | +$2.42M | 0.08% | 347 |
|